BASEL (dpa-AFX) – The Swiss pharmaceutical company Novartis wants to take over the biotech company MorphoSys. Morphosys shareholders will be offered 68 euros per share, Novartis and Morphosys announced on Monday evening. This corresponds to a premium of 94 percent on the volume-weighted average price of the last month before January 25, 2024. The first takeover speculation arose on this date. Novartis is putting a total of 2.7 billion euros on the table. The Reuters news agency had already reported on the Novartis bid for the SDax company Morphosys on Monday afternoon./stk
Selected leveraged products on MorphoSys
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on MorphoSys
The leverage must be between 2 and 20
Advertising